Active ETFs Are Winning by Being Less Active

Active ETFs took 37% of last week's industry flows on a shelf barely three years old, roughly three times their share of assets by PWD's tracking. Young categories routinely out-collect their asset base, but a three-to-one lead is unusual for a young category, and it marks a wrapper being bought faster than the strategies inside it can prove themselves.

The products collecting that money are worth reading as a set, because they share a construction that has little to do with stock selection. MFS launched a taxable and a tax-exempt short-duration bond ETF at a single 0.25% fee; Goldman Sachs Asset Management is pitching artificial intelligence through a dispersion figure it calls the strongest quantitative case for active management in years; ALPS built a REIT fund whose healthcare overweight is 21.65% of the book. Three labels, three mandates, one building method: rules that fit on a page, priced near the index, sold as an idea.

The flow share follows from that pattern, and with it the fee economics of active management come apart. The wrapper sells a packaged version of a strategy a buyer could otherwise assemble from an index and a screen, priced against the index next door, and migration at this size leaves little room for the experience premium incumbents have long sold—the argument that a long-tenured manager is the safer hand, because a track record does not travel into a new vehicle intact.

Start with MFS, because the fee is the product: both twins launched at 0.25%, a price that lands in index territory rather than in the range active fixed income has historically commanded and undercuts what active peers charge for comparable duration. Charging one price for a taxable and a tax-exempt short-duration strategy is a packaging decision before it is a portfolio decision; the two share a duration band and little else, since they sell to different buyers, sit on different curves and answer to different demand cycles. Identical pricing bets that the wrapper, more than the tax treatment, is expected to close the sale, and it commits the firm to a fee the rate cycle will outlive—short-duration demand exists because the front end has been paying, and when the front end stops paying, the 25 basis points remain.

Goldman's pitch is the more interesting one because it is the only product in this group making a real case for selection, and dispersion—the spread between the best and worst outcomes in a market—is the arithmetic under every active fee, since a market where every stock returned the same would need no managers. GSAM's framing is that dispersion is wide enough to fund selection, a sound argument and a conditional one. Dispersion is a market condition, not a property of the fund, and a manager selling it is selling a forecast it cannot control. GSAM's own framing shows what would have to change for the case to hold: if the spread narrows, the arithmetic stops working and the fee has to fall back toward the rest of the shelf.

The argument contains its own self-limiting element: if dispersion draws assets toward the managers who exploit it, enough capital eventually compresses the spread, and the arithmetic that justified the fee weakens with it. That makes GSAM's case cyclical rather than permanent, a harder thing to charge an active fee for.

ALPS gives the construction away through its weights: healthcare REITs at 21.65% of the book is a sub-segment bet wearing a stock-picker's label, and what decides that fund's return is occupancy, leverage and the cost of capital inside one corner of the REIT market, numbers that arrive from the holdings rather than from the manager. The tilt is a legitimate product and, at bottom, an index with a sector weight.

Narrow mandates keep arriving for a reason, and they carry a cost: complex products are being listed faster than the desks that quote them can price the baskets behind them, and the finer the tilt, the harder the underlying is to borrow, hedge and quote. A healthcare-REIT overweight is liquid enough to absorb; the tilts further down the shelf are where that bottleneck will show up first.

The gap between the flow share and the asset share is also a capacity question the shelf has not answered, because money arriving at three times the rate of the asset base has to be put to work, and a rules-based product absorbs it more easily than a concentrated one—one more reason the flow is landing in tilts and screens rather than in high-conviction portfolios.